首页> 外文期刊>Urology >Adjuvant radiotherapy use and patterns of care analysis for margin-positive prostate adenocarcinoma with extracapsular extension: postprostatectomy adjuvant radiotherapy: a SEER analysis.
【24h】

Adjuvant radiotherapy use and patterns of care analysis for margin-positive prostate adenocarcinoma with extracapsular extension: postprostatectomy adjuvant radiotherapy: a SEER analysis.

机译:伴有包膜外延伸的边缘阳性前列腺腺癌的辅助放疗使用和护理分析模式:前列腺切除术后辅助放疗:SEER分析。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: To perform a patterns of care analysis for patients with prostate cancer and high-risk pathologic factors following radical prostatectomy with regards to adjuvant radiation. METHODS: A retrospective analysis was conducted using the Surveillance, Epidemiology and End Results (SEER) Program. We identified men from 2004 to 2005 with prostate adenocarcinoma (PA) who had undergone radical prostatectomy (RP) and were found to have extracapsular extension (ECE) with positive margins. RESULTS: We identified 1427 PA patients with ECE and positive margins after an RP. Most were clinically staged as T1 or T2 before surgery (95.8%). Using the D'Amico Risk Stratification, 52.0% were high-risk, 39.7% were intermediate-risk, and 8.3% were low-risk. Of these, 18.2% (260) received ART, whereas 81.8% (1167) did not. Those who received ART had worse prognostic factors, such as Gleason scores > 7 (38.5% vs 24.8%; P < .0001), prostate-specific antigen level > 10 (44.6% vs 35.2%; P = .0045), pathologically positive lymph nodes (11.5% vs 6.4%; P = .006), and D'Amico high-risk disease (66.8% vs 48.7%; P < .0001). The use of ART based on geographic region ranged from 8.3%-34.2%. CONCLUSIONS: Less than 20% of patients with pT3 disease and positive margins received ART in the study period just before the publication of randomized data demonstrating an improvement in biochemical failure with ART in this SEER retrospective analysis. This is the largest patterns of care analysis to date of ART in patients with margin-positive pT3 prostate adenocarcinoma.
机译:目的:对前列腺癌根治性前列腺切除术后辅助放射治疗的前列腺癌和高危病理因素患者进行护理分析。方法:使用监测,流行病学和最终结果(SEER)程序进行回顾性分析。我们确定了2004年至2005年患有前列腺腺癌(PA)的男性,这些男性接受了前列腺癌根治术(RP),并被发现囊外延伸(ECE)且切缘阳性。结果:我们确定了1427名PA患者的ECE和RP后的切缘阳性。大多数患者在手术前被临床分期为T1或T2(95.8%)。使用D'Amico风险分层,高风险为52.0%,中风险为39.7%,低风险为8.3%。其中,有18.2%(260)接受抗逆转录病毒治疗,而有81.8%(1167)没有接受抗逆转录病毒治疗。那些接受ART的患者的预后因素较差,例如格里森评分> 7(38.5%vs 24.8%; P <.0001),前列腺特异性抗原水平> 10(44.6%vs 35.2%; P = .0045),病理学阳性淋巴结转移(11.5%vs 6.4%; P = .006)和达米科高危疾病(66.8%vs 48.7%; P <.0001)。基于地理区域的ART使用范围为8.3%-34.2%。结论:在随机数据公布之前的研究期间,只有不到20%的pT3疾病和切缘阳性的患者接受了抗逆转录病毒治疗,这表明在该SEER回顾性分析中抗逆转录病毒治疗可改善生化衰竭。这是迄今为止对边缘阳性pT3前列腺腺癌患者进行ART治疗的最大分析模式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号